• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘油/氨基酸/葡萄糖透析液对慢性肾衰竭患者腹膜间皮细胞的影响。

The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritoneal membrane in chronic renal failure.

机构信息

Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Perit Dial Int. 2010 Mar-Apr;30(2):192-200. doi: 10.3747/pdi.2008.00159. Epub 2010 Feb 1.

DOI:10.3747/pdi.2008.00159
PMID:20124192
Abstract

BACKGROUND

Long-term peritoneal dialysis (PD) with conventional glucose based, lactate-buffered PD fluids may lead to morphological and functional alterations of the peritoneal membrane. It was hypothesized that long-term exposure to a different buffer and a mixture of osmotic agents would cause less peritoneal abnormality.

OBJECTIVES

To investigate the effects of long-term exposure to a bicarbonate/lactate-buffered dialysis solution with a mixture of osmotic agents: glycerol 1.4%, amino acids 0.5%, and dextrose 1.1% (= 1% glucose) (GLAD) in a rat model with chronic kidney failure.

METHODS

All rats underwent a peritoneal catheter implantation and a 70% nephrectomy. Thereafter, the rats were randomly divided into 3 groups: GLAD, 3.86% Dianeal (Baxter, Nivelles, Belgium), and buffer (Physioneal without glucose, Baxter). All rats were infused daily for 16 weeks with the appropriate PD fluid. Afterwards, a peritoneal permeability analysis (SPARa) was performed using 3.86% Physioneal in all groups. After the SPARa, the rats were sacrificed to obtain tissue samples for morphometric determinations. Omental tissue was stained with picro Sirius red for assessment of fibrosis and with CD31 for vessel density.

RESULTS

GLAD and Dianeal showed faster small solute transport compared to the hypotonic buffer. No differences between the groups were present in ultrafiltration. Dianeal had the lowest value for free water transport and the highest protein clearances. Total triglyceride in plasma was not different between GLAD and the buffer. Vessel density after GLAD exposure (20 V/F) was very similar to the value found for the buffer solution (17 V/F); Dianeal caused a significantly higher value (35 V/F, p < 0.01). Also, the amount of fibrosis was higher in the Dianeal-exposed rats (p < 0.01).

CONCLUSION

Both hypertonic dialysis solutions increased peritoneal solute transport. GLAD exposure was associated with the best preservation of peritoneal morphology. The results of GLAD were very similar to those of the bicarbonate/lactate-buffered solution without osmotic agents. Studies in humans are needed for further assessment of GLAD.

摘要

背景

长期使用基于葡萄糖的常规乳酸盐缓冲腹膜透析(PD)液可能会导致腹膜形态和功能发生改变。有人假设,长期接触不同的缓冲液和混合渗透剂会导致较少的腹膜异常。

目的

研究在慢性肾衰竭大鼠模型中,长期暴露于碳酸氢盐/乳酸盐缓冲透析液与混合渗透剂(甘油 1.4%、氨基酸 0.5%和 1.1%葡萄糖[=1%葡萄糖](GLAD))的影响。

方法

所有大鼠均行腹膜导管植入和 70%肾切除术。此后,大鼠随机分为 3 组:GLAD、3.86% Dianeal(百特,Nivelles,比利时)和缓冲液(无葡萄糖的 Physioneal,百特)。所有大鼠均每日接受适当的 PD 液输注 16 周。之后,所有组均使用 3.86% Physioneal 进行腹膜通透性分析(SPARa)。SPARa 后,处死大鼠获取组织样本进行形态计量学测定。大网膜组织用苦味酸天狼猩红染色评估纤维化,用 CD31 评估血管密度。

结果

GLAD 和 Dianeal 与低渗缓冲液相比,小分子溶质转运更快。超滤在各组之间无差异。Dianeal 的游离水转运率最低,蛋白清除率最高。GLAD 与缓冲液组的血浆总三酰甘油无差异。GLAD 暴露后的血管密度(20 V/F)与缓冲液溶液的测量值非常相似(17 V/F);Dianeal 导致的血管密度显著更高(35 V/F,p < 0.01)。此外,Dianeal 暴露大鼠的纤维化程度更高(p < 0.01)。

结论

两种高渗透析液均增加了腹膜溶质转运。GLAD 暴露与腹膜形态的最佳保留相关。GLAD 的结果与无渗透剂的碳酸氢盐/乳酸盐缓冲液非常相似。需要进行人体研究以进一步评估 GLAD。

相似文献

1
The effects of a dialysis solution with a combination of glycerol/amino acids/dextrose on the peritoneal membrane in chronic renal failure.甘油/氨基酸/葡萄糖透析液对慢性肾衰竭患者腹膜间皮细胞的影响。
Perit Dial Int. 2010 Mar-Apr;30(2):192-200. doi: 10.3747/pdi.2008.00159. Epub 2010 Feb 1.
2
Addition of a nitric oxide inhibitor to a more biocompatible peritoneal dialysis solution in a rat model of chronic renal failure.
Adv Perit Dial. 2010;26:7-11.
3
Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations.在大鼠的长期腹膜暴露模型中诱导慢性肾衰竭:对功能性和结构性腹膜改变的影响。
Perit Dial Int. 2010 Sep-Oct;30(5):558-69. doi: 10.3747/pdi.2008.00272. Epub 2010 Apr 26.
4
Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore.实验性腹膜硬化模型不应再基于葡萄糖酸洗必泰。
Nephron Exp Nephrol. 2011;117(1):e1-8. doi: 10.1159/000319651. Epub 2010 Aug 4.
5
Lymphangiogenesis and Lymphatic Absorption Are Related and Increased in Chronic Kidney Failure, Independent of Exposure to Dialysis Solutions.淋巴管生成与淋巴吸收相关,且在慢性肾衰竭中增加,与透析液暴露无关。
Adv Perit Dial. 2015;31:21-5.
6
A pyruvate-buffered dialysis fluid induces less peritoneal angiogenesis and fibrosis than a conventional solution.与传统溶液相比,丙酮酸缓冲透析液诱导的腹膜血管生成和纤维化较少。
Perit Dial Int. 2008 Sep-Oct;28(5):487-96.
7
Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.长期接触新型腹膜透析液:对腹膜的影响。
Kidney Int. 2004 Sep;66(3):1257-65. doi: 10.1111/j.1523-1755.2004.00879.x.
8
Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD?降低腹膜透析液中乳酸盐和葡萄糖含量对腹膜的影响。未来会是葡萄糖乳酸盐替代透析液(GLAD)吗?
NDT Plus. 2008 Oct;1(Suppl 4):iv56-iv62. doi: 10.1093/ndtplus/sfn126.
9
Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.腹膜透析液的生物相容性:非尿毒症大鼠的长期暴露
Perit Dial Int. 2004 Jan-Feb;24(1):37-47.
10
Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.碳酸氢盐/乳酸缓冲的PDF生物相容性的改善与pH无关。
Nephrol Dial Transplant. 2006 Jan;21(1):208-16. doi: 10.1093/ndt/gfi188. Epub 2005 Nov 1.

引用本文的文献

1
Clinical and preclinical studies of mesenchymal stem cells to alleviate peritoneal fibrosis.间充质干细胞缓解腹膜纤维化的临床前和临床研究。
Stem Cell Res Ther. 2024 Jul 30;15(1):237. doi: 10.1186/s13287-024-03849-3.
2
Mechanisms of human umbilical cord mesenchymal stem cells-derived exosomal lncRNA GAS5 in alleviating EMT of HPMCs via Wnt/β-catenin signaling pathway.人脐带间充质干细胞来源的外泌体 lncRNA GAS5 通过 Wnt/β-catenin 信号通路缓解 HPMCs 的 EMT 机制。
Aging (Albany NY). 2023 May 23;15(10):4144-4158. doi: 10.18632/aging.204719.
3
Aging of the Peritoneal Dialysis Membrane.
腹膜透析膜的老化
Front Physiol. 2022 Apr 28;13:885802. doi: 10.3389/fphys.2022.885802. eCollection 2022.
4
LncRNA GAS5 Competitively Combined With miR-21 Regulates PTEN and Influences EMT of Peritoneal Mesothelial Cells via Wnt/β-Catenin Signaling Pathway.长链非编码RNA GAS5与miR-21竞争性结合,通过Wnt/β-连环蛋白信号通路调控PTEN并影响腹膜间皮细胞的上皮-间质转化。
Front Physiol. 2021 Aug 30;12:654951. doi: 10.3389/fphys.2021.654951. eCollection 2021.
5
How to Improve the Biocompatibility of Peritoneal Dialysis Solutions (without Jeopardizing the Patient's Health).如何提高腹膜透析液的生物相容性(同时不损害患者健康)。
Int J Mol Sci. 2021 Jul 26;22(15):7955. doi: 10.3390/ijms22157955.
6
The osmo-metabolic approach: a novel and tantalizing glucose-sparing strategy in peritoneal dialysis.渗透压-代谢平衡策略:腹膜透析中一种新颖且诱人的葡萄糖节约策略。
J Nephrol. 2021 Apr;34(2):503-519. doi: 10.1007/s40620-020-00804-2. Epub 2020 Aug 7.
7
New Insights into the Effects of Chronic Kidney Failure and Dialysate Exposure on the Peritoneum.慢性肾衰竭及透析液暴露对腹膜影响的新见解
Perit Dial Int. 2016;36(6):614-622. doi: 10.3747/pdi.2015.00204. Epub 2016 May 4.
8
Identification of Gene Transcripts Implicated in Peritoneal Membrane Alterations.与腹膜改变相关的基因转录本的鉴定
Perit Dial Int. 2016;36(6):606-613. doi: 10.3747/pdi.2015.00094. Epub 2016 May 4.
9
Peritoneal dialysis: from bench to bedside.腹膜透析:从实验台到临床应用
Clin Kidney J. 2013 Dec;6(6):568-77. doi: 10.1093/ckj/sft122. Epub 2013 Oct 14.
10
An update on peritoneal dialysis solutions.腹膜透析液的最新进展。
Nat Rev Nephrol. 2012 Feb 21;8(4):224-33. doi: 10.1038/nrneph.2012.13.